UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

The American journal of medicine, 2012, Vol.125 (1), p.S3-S13

Pfaller, Michael A., MD

2012

Volltextzugriff (PDF)

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Clinical Microbiology Reviews, 2007-01, Vol.20 (1), p.133-163

2007

Volltextzugriff (PDF)

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Journal of Clinical Microbiology, 2012-09, Vol.50 (9), p.2846-2856

2012

Volltextzugriff (PDF)

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Volltextzugriff (PDF)

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S79-S94

2019

Volltextzugriff (PDF)

Epidemiology of Invasive Mycoses in North America

Critical reviews in microbiology, 2010-02, Vol.36 (1), p.1-53

2010

Volltextzugriff (PDF)

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

Journal of Clinical Microbiology, 2012-04, Vol.50 (4), p.1199-1203

2012

Volltextzugriff (PDF)

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1695-1703

2009

Volltextzugriff (PDF)

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.150-156

2008

Volltextzugriff (PDF)

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Journal of Clinical Microbiology, 2010-04, Vol.48 (4), p.1366-1377

2010

Volltextzugriff (PDF)

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2497-2506

2010

Volltextzugriff (PDF)

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Journal of Clinical Microbiology, 2010-09, Vol.48 (9), p.3251-3257

2010

Volltextzugriff (PDF)

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2571-2581

2013

Volltextzugriff (PDF)

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

International journal of antimicrobial agents, 2020-01, Vol.55 (1), p.105799-105799, Article 105799

2020

Volltextzugriff (PDF)

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Volltextzugriff (PDF)

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S47-S53

2019

Volltextzugriff (PDF)

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

Journal of clinical microbiology, 2004-10, Vol.42 (10), p.4419-4431

2004

Volltextzugriff (PDF)

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.760-763

2006

Volltextzugriff (PDF)

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Future microbiology, 2016-01, Vol.11 (1), p.103-117

2016

Volltextzugriff (PDF)

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.561-566

2011

Volltextzugriff (PDF)

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.5836-5842

2013

Volltextzugriff (PDF)

1 – 25 von 2.407

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.826)
Mit Volltextzugriff
(2.062)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.243)
Deutsch
(160)
Spanisch
(4)
Portugiesisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.277)
Life Sciences & Biomedicine
(1.188)
Humans
(857)
Biological And Medical Sciences
(744)
Microbiology
(734)
Medical Sciences
(531)
Infectious Diseases
(498)
Microbial Sensitivity Tests
(366)
Fundamental And Applied Biological Sciences. Psychology
(346)
Pharmacology. Drug Treatments
(297)
Antifungal Agents - Pharmacology
(289)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(284)
Mycology
(226)
Animals
(220)
Candida - Drug Effects
(205)
Pharmacology & Pharmacy
(193)
Male
(181)
Female
(164)
Antifungal Agents
(156)
Candida
(153)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.173)
EZB Electronic Journals Library
(986)
Ingenta
(710)
Journals@Ovid Full Text
(513)
Elsevier ScienceDirect Journals
(461)
Ebook Central Perpetual and DDA
(410)
eBooks on EBSCOhost
(407)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(386)
Single Journals
(294)
JSTOR All Journals
(182)
Oxford journals
(178)
IngentaConnect Journals
(178)
SpringerLink
(165)
Oxford Journals 2020 Medicine
(158)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(127)
Wiley Online Library
(119)
Wiley Online Library
(82)
Taylor & Francis Journals
(67)
Taylor & Francis Online
(56)
Taylor & Francis
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Epidemiology of Invasive Mycoses in North America

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Aktive Filter

Suchergebnisse filtern